Home - Products - MAPK/ERK Signaling - MNK - MNK1/2-IN-5

MNK1/2-IN-5

CAS No. 1426928-20-2

MNK1/2-IN-5( —— )

Catalog No. M35464 CAS No. 1426928-20-2

MNK1/2-IN-5 is a potent and selective MNK1/2 inhibitor with anticancer activity and can be used to study solid tumors and hematological malignancies.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	141	In Stock
2MG	79	In Stock
5MG	132	In Stock
10MG	198	In Stock
25MG	356	In Stock
50MG	513	In Stock
100MG	732	In Stock
200MG	1004	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

MNK1/2-IN-5
Note

Research use only, not for human use.
Brief Description

MNK1/2-IN-5 is a potent and selective MNK1/2 inhibitor with anticancer activity and can be used to study solid tumors and hematological malignancies.
Description

MNK1/2-IN-5 is a potent and selective MNK1/2 inhibitor as a therapeutic agent.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

MNK
Recptor

MNK
Research Area

——
Indication

——

Chemical Information

CAS Number

1426928-20-2
Formula Weight

308.33
Molecular Formula

C17H16N4O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 7.14 mg/mL (23.16 mM; Ultrasonic (<60°C)
SMILES

O([C@@H](CN)C)C1=NN2C(=CN=C2C=C1)C3=CC=4C(O3)=CC=CC4
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Xu W, et al. Update on the Development of MNK Inhibitors as Therapeutic Agents. J Med Chem. 2021 Sep 17.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

SEL-201

SEL-201 (SLV-2436, SEL201-88) is a novel potent, selective, ATP-competitive and oral MNK1/2 inhibitor.
eFT508

eFT508 (Tomivosertib) is a?potent, highly selective, reversible, ATP-competitive, and orally bioavailable MNK1 and MNK2 inhibitor with IC50 of 1-2 nM in enzyme assays.
QL-X-138

QL-X-138 is a selective and potent BTK/MNK dual kinase inhibitor with IC50 of 8, 107.4, and 26 nM for BTK, MNK1, and MNK2, respectively.

Sign In Join Free